Digg
Del.icio.us
Yahoo
Google
Newsvine
Advancing Therapies for Patients
Sarah Cannon Research Institute
The increasing availability of novel agents and therapeutic strategies has advanced the treatment paradigm for patients with multiple myeloma, lymphomas, leukemias, and myelodysplastic syndromes. In this program, participants will review the latest advances for the treatment of hematologic malignancies that were presented at the 53rd American Society of Hematology Annual Meeting and Exposition.
This activity is intended for active hematology and oncology physicians, nurses, pharmacists, and other healthcare professionals who manage patients with hematologic malignancies.
This activity has been approved for AMA PRA Category 1 Credit™. For more information please contact askSARAH at 1-877-691-7274.
Our News
View All News-
SCRI in the News
January 26, 2012
-
NBJ announces the Forty Under 40 class of 2012
January 25, 2012
Congratulations are in order for the Nashville Business Journal’s Forty Under 40 class of 2012. The following 40 winners, first named during a reveal party Tuesday night at Nashville City Club , were deemed to be making a difference in their companies and community by a panel of judges.
-
World-class care right here at home
January 23, 2012
When it arrives, a diagnosis of cancer can be among the most devastating of news to a patient and their families. For local residents, the course of treatment has often meant weekly trips to nearby Murfreesboro or Nashville for chemotherapy.
Community Based Research
-
SCRI Locations
- More than 700 physicians
- Multiple therapeutic areas
- United Kingdom and Global Services -
Scientific Excellence
Nine Physicians Associated with Sarah Cannon Research Institute Named to Best Doctors List